ATE289611T1 - Peptide und pharmazeutische zusammensetzungen, die diese enthalten - Google Patents
Peptide und pharmazeutische zusammensetzungen, die diese enthaltenInfo
- Publication number
- ATE289611T1 ATE289611T1 AT95937323T AT95937323T ATE289611T1 AT E289611 T1 ATE289611 T1 AT E289611T1 AT 95937323 T AT95937323 T AT 95937323T AT 95937323 T AT95937323 T AT 95937323T AT E289611 T1 ATE289611 T1 AT E289611T1
- Authority
- AT
- Austria
- Prior art keywords
- cells
- peptides
- pharmaceutical compositions
- compositions containing
- containing same
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 4
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 208000035408 type 1 diabetes mellitus 1 Diseases 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4621—Cellular immunotherapy characterized by the effect or the function of the cells immunosuppressive or immunotolerising
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/46433—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL11119694A IL111196A0 (en) | 1994-10-07 | 1994-10-07 | Peptides and pharmaceutical compositions comprising them |
| PCT/US1995/012686 WO1996011214A1 (en) | 1994-10-07 | 1995-10-10 | Peptides and pharmaceutical compositions comprising them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE289611T1 true ATE289611T1 (de) | 2005-03-15 |
Family
ID=11066614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95937323T ATE289611T1 (de) | 1994-10-07 | 1995-10-10 | Peptide und pharmazeutische zusammensetzungen, die diese enthalten |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0783524B1 (de) |
| JP (1) | JPH10507345A (de) |
| KR (1) | KR100381711B1 (de) |
| AT (1) | ATE289611T1 (de) |
| AU (1) | AU708301B2 (de) |
| CA (1) | CA2201935A1 (de) |
| CZ (1) | CZ103197A3 (de) |
| DE (1) | DE69534024T2 (de) |
| FI (1) | FI971427A (de) |
| HU (1) | HUT77484A (de) |
| IL (1) | IL111196A0 (de) |
| NO (1) | NO971517L (de) |
| PL (1) | PL319831A1 (de) |
| SK (1) | SK44197A3 (de) |
| WO (1) | WO1996011214A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6716963B1 (en) | 1998-05-22 | 2004-04-06 | Abbott Laboratories | Peptide antiangiogenic drugs |
| SI2319928T1 (sl) | 1998-10-23 | 2013-08-30 | Kirin-Amgen, Inc. | Dimerni trombopoietinski peptidni mimetiki, ki se veĺ˝ejo na receptor mp1 in imajo trombopoietinsko aktivnost |
| US7488590B2 (en) | 1998-10-23 | 2009-02-10 | Amgen Inc. | Modified peptides as therapeutic agents |
| US6660843B1 (en) | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
| JP2008505928A (ja) | 2004-07-08 | 2008-02-28 | アムジェン インコーポレーテッド | 治療用ペプチド |
| US8008453B2 (en) | 2005-08-12 | 2011-08-30 | Amgen Inc. | Modified Fc molecules |
| US20170174764A1 (en) * | 2014-03-27 | 2017-06-22 | Yeda Research And Development Co. Ltd. | T-cell receptor cdr3 peptides and antibodies |
| IL292311A (en) | 2014-04-03 | 2022-06-01 | Igm Biosciences Inc | J-chain qualified |
| DK3356401T3 (da) | 2015-09-30 | 2020-09-07 | Igm Biosciences Inc | Bindingsmolekyler med modificeret j-kæde |
| CA2999284C (en) | 2015-09-30 | 2023-06-13 | Igm Biosciences A/S | Binding molecules with modified j-chain |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4886743A (en) * | 1985-04-24 | 1989-12-12 | California Institute Of Technology | Diagnostic reagents based on unique sequences within the variable region of the T cell receptor and uses thereof |
-
1994
- 1994-10-07 IL IL11119694A patent/IL111196A0/xx unknown
-
1995
- 1995-10-10 JP JP8512640A patent/JPH10507345A/ja active Pending
- 1995-10-10 AT AT95937323T patent/ATE289611T1/de active IP Right Revival
- 1995-10-10 KR KR1019970702283A patent/KR100381711B1/ko not_active IP Right Cessation
- 1995-10-10 EP EP95937323A patent/EP0783524B1/de not_active Expired - Lifetime
- 1995-10-10 WO PCT/US1995/012686 patent/WO1996011214A1/en active IP Right Grant
- 1995-10-10 AU AU39462/95A patent/AU708301B2/en not_active Ceased
- 1995-10-10 HU HU9800152A patent/HUT77484A/hu unknown
- 1995-10-10 SK SK441-97A patent/SK44197A3/sk unknown
- 1995-10-10 CA CA002201935A patent/CA2201935A1/en not_active Abandoned
- 1995-10-10 DE DE69534024T patent/DE69534024T2/de not_active Expired - Lifetime
- 1995-10-10 PL PL95319831A patent/PL319831A1/xx unknown
- 1995-10-10 CZ CZ971031A patent/CZ103197A3/cs unknown
-
1997
- 1997-04-03 NO NO971517A patent/NO971517L/no not_active Application Discontinuation
- 1997-04-04 FI FI971427A patent/FI971427A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI971427A0 (fi) | 1997-04-04 |
| KR970706306A (ko) | 1997-11-03 |
| EP0783524A4 (de) | 2000-05-17 |
| AU708301B2 (en) | 1999-07-29 |
| SK44197A3 (en) | 1997-11-05 |
| PL319831A1 (en) | 1997-09-01 |
| CZ103197A3 (en) | 1997-09-17 |
| FI971427A (fi) | 1997-05-26 |
| EP0783524A1 (de) | 1997-07-16 |
| AU3946295A (en) | 1996-05-02 |
| NO971517L (no) | 1997-05-22 |
| EP0783524B1 (de) | 2005-02-23 |
| NO971517D0 (no) | 1997-04-03 |
| KR100381711B1 (ko) | 2003-07-16 |
| WO1996011214A1 (en) | 1996-04-18 |
| JPH10507345A (ja) | 1998-07-21 |
| CA2201935A1 (en) | 1996-04-18 |
| HUT77484A (hu) | 1998-05-28 |
| DE69534024D1 (de) | 2005-03-31 |
| IL111196A0 (en) | 1994-12-29 |
| DE69534024T2 (de) | 2006-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0671920A4 (de) | Ein anti-idiotypischer antikörper und seine verwendung in der diagnose und therapie von hiv-verwandten krankheiten. | |
| CA2219988A1 (en) | Cd16-ii variants | |
| BRPI9708566A (pt) | Análogo de glp-2, análogo de peptìdeo glp-humano, peptìdeo, composição farmacêutica, uso de um análogo de glp-2, e, processo para identificar análogos intestinotróficos de glp-2. | |
| DE69839782D1 (de) | Eine Zusammensetzung, die eine Trägerkomponente und eine gereinigte mykobakterielle Zellwandkomponente enthält, und ihre Verwendung zur Verhinderung, Behandlung und Diagnose von Erkrankungen | |
| ATE220924T1 (de) | Kaskaden-polymer-komplexe, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel | |
| ATE175114T1 (de) | Pharmazeutische zusammensetzungen enthaltend einen opiat antagonist und calcium salze, ihre verwendung zur behandlung von endorphin- vermittelten krankheiten | |
| YU18799A (sh) | Monociklični l-nukleozidi, njihovi analozi i njihova upotreba | |
| HUP0001293A1 (hu) | Heterociklusos vegyületek és ezeket tartalmazó gyógyászati készítmények béta-amiloid-peptidek gátlására | |
| ATE241365T1 (de) | Saccharid-enthaltende zubereitungen zur behandlung von alzheimerschen erkrankung und von weiteren amyloidosen | |
| NZ504026A (en) | Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C | |
| ATE236870T1 (de) | Substituierte 2-phenyl-1-(3,4-dihydroxy-5- nitrophenyl)-1-ethanone, deren verwendung zur behandlung von erkrankungen des zentralen und periphären nervensystems und diese enthaltende pharmazeutische zusammensetzungen | |
| ATE242005T1 (de) | P277 peptidanaloge, pharmazeutische zusammenstellung davon zur behandlung und diagnose von diabetes | |
| ATE289611T1 (de) | Peptide und pharmazeutische zusammensetzungen, die diese enthalten | |
| DE69311541T2 (de) | Kosmetische oder pharmazeutische zusammensetzungen zur topischen anwendung die deacylierten glycerophospholipide enthalten | |
| ES2156215T3 (es) | Utilizacion de un conjugado en el tratamiento y/o diagnostico de enfermedades inflamatorias. | |
| HUP9901303A2 (hu) | Gyógyszerkészítmény autoimmun betegségek kezelésére | |
| RU94006580A (ru) | Адаптоген трекрезан в медицине | |
| ID23184A (id) | Garam-garam peptida bpc dengan aktivitas organoprotektif proses pembuatan dan penggunaannya dalam terapi | |
| ATE264112T1 (de) | Verwendung von il-7 zur behandlung von autoimmunkrankheiten, insbesondere insulinabhängigem diabetes mellitus | |
| DE59006159D1 (de) | Verwendung von macrolactonen als antiallergica. | |
| DE69421705T2 (de) | Verwendung von Efaroxan und dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung neurogenerativer Erkrankungen | |
| RU93030389A (ru) | Средство, восстанавливающее функцию сетчатой оболочки глаза | |
| ATE82016T1 (de) | 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel. | |
| RU94037232A (ru) | Пептиды с органозащитной активностью, способ их получения и их применение | |
| DE68914886T2 (de) | Mittel zur Behandlung von Raynaud's Krankheit. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties | ||
| EEWE | Authorization for restitution | ||
| UEP | Publication of translation of european patent specification |
Ref document number: 0783524 Country of ref document: EP |